Pick Disease Drugs Development Market Analysis
May 1, 2023 ⚊ 1 Min read ⚊ Views 77 ⚊ TECHNOLOGY
The Pick disease drugs development market is expected to grow significantly in the coming years, driven by the growing prevalence of the disease and the lack of effective treatments. According to a report by ResearchAndMarkets, the global frontotemporal disorders treatment market, which includes Pick disease, is expected to grow at a compound annual growth rate (CAGR) of 16.1% from 2020 to 2027.
Several pharmaceutical companies are actively involved in the development of new drugs for Pick disease. The key players in the market include Biogen, Genentech, AbbVie, and TauRx.
Tags: Pick Disease Drugs in Development
